Amanote Research
Register
Sign In
Randomized, Prospective, and Double-Blind Trial of New Beta-Lactams in the Treatment of Appendicitis.
Antimicrobial Agents and Chemotherapy
- United States
doi 10.1128/aac.28.5.639
Full Text
Open PDF
Abstract
Available in
full text
Categories
Infectious Diseases
Pharmacology
Date
November 1, 1985
Authors
W Y Lau
S T Fan
K W Chu
H C Suen
T F Yiu
K K Wong
Publisher
American Society for Microbiology
Related search
Quetiapine Versus Haloperidol in the Treatment of Delirium: A Double-Blind, Randomized, Controlled Trial
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Treatment of Chronic Antibody Mediated Rejection With Intravenous Immunoglobulins and Rituximab: A Multicenter, Prospective, Randomized, Double Blind Clinical Trial
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Randomized, Double-Blind Trial of Cefonicid and Nafcillin in the Treatment of Skin and Skin Structure Infections.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Aripiprazole for the Treatment of Methamphetamine Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial
Addiction
Medicine
Psychiatry
Mental Health
A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal Syndrome
Gastroenterology
Hepatology
Gastroenterology
Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Oxytocin Nasal Spray in the Treatment of Binge Eating Disorder and Obesity: A Pilot, Randomized, Double-Blind Trial
Clinical Pharmacology & Biopharmaceutics
Efficacy of the LED Red Light Therapy in the Treatment of Temporomandibular Disorders: Double Blind Randomized Controlled Trial
Pain Research and Treatment
Neurology
Anesthesiology
Pain Medicine
Double-Blind, Randomized, Controlled Clinical Trial of Norfloxacin for Cholera.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
